Human CRF2 α and β splice variants: Pharmacological characterization using radioligand binding and a luciferase gene expression assay

Neuropharmacology

Volumn 38, Issue 3, 1999, Pages 441-448

  Ardati, Ali ^b   Goetschy, Valerie ^a   Gottowick, Juergen ^a   Henriot, Stephane ^a   Valdenaire, Olivier ^a   Deuschle, Ulrich ^a   Kilpatrick, Gavin J ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIC AMP; LUCIFERASE; SAUVAGINE; CRF RECEPTOR TYPE 2; GUANYLYLIMIDODIPHOSPHATE; HYBRID PROTEIN; ISOPROTEIN; PEPTIDE; RADIOACTIVE IODINE; SAUVAGINE, TYR(0); SAUVAGINE, TYR(0)-; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KINETICS; PRIORITY JOURNAL; PROTEIN VARIANT; RECEPTOR BINDING; RNA SPLICING; ALTERNATIVE RNA SPLICING; ANIMAL; BIOSYNTHESIS; BRAIN; CELL LINE; CELL MEMBRANE; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENETICS; METABOLISM; PROMOTER REGION; RADIOASSAY; RAT; REPORTER GENE;

ALTERNATIVE SPLICING; ANIMALS; BRAIN; CELL LINE; CELL MEMBRANE; GENES, REPORTER; GUANYLYL IMIDODIPHOSPHATE; HUMANS; IODINE RADIOISOTOPES; KINETICS; LUCIFERASES; PEPTIDES; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RADIOLIGAND ASSAY; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECOMBINANT FUSION PROTEINS; TRANSFECTION; VARIATION (GENETICS); VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032586765     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00201-9     Document Type: Article

References (22)

1. 14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides. Mol. Pharmacol. 51, 816-824.
2. Behan, D.P., Heinrichs, S.C., Troncoso, J.C., Liu, X.-J., Kawas, C.H., Ling, N., De Souza, E.B., 1995. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature (Lond.) 378, 284-287.
3. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. De Souza, E.B., 1995. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20, 789-819.
5. Fink, J.S., Verhave, M., Kasper, S., Tsukada, T., Mandel, G., Goodman, R.H., 1988. The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer. Proc. Natl. Acad. Sci. USA 85, 6662-6666.
6. Gonzalez, G.A, Montminy, M.R., 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680.
7. Gossen, M., Bujard, H., 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551.
8. 3H]-urocortin. Neuropharmacology 36, 1439-1446.
9. 2α receptors. Mol. Pharmacol. 50, 679-686.
10. Hagiwara, M., Brindle, P., Harootunian, A., Armstrong, R., Rivier, J., Vale, W., Tsien, R., Montminy, M.R., 1993. Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol. Cell. Biol. 13, 4852-4859.
11. Kishimoto, T., Pearse II, R.V., Lin, C.R., Rosenfeld, M.G., 1995. A sauvagine/corticotropin releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 92, 1108-1112.
12. Liaw, C.W., Lovenberg, T.W., Barry, G., Oltersdorf, T., Grigoriadis, D.E., De Souza, E.B., 1996. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137, 72-77.
13. 2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136, 4139-4142.
14. Lovenberg, T.W., Liaw, C.W., Grigoriadis, D.E., Clevenger, W., Chalmers, D.T., De Souza, E.B., Oltersdorf, T., 1995. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA 92, 836-840.
15. McPherson, G.A., 1985. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J. Pharmacol. Method. 4, 213-228.
16. Munson, P.J., Rodbard, D., 1980. Ligand: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107, 202-239.
17. Perrin, M., Donaldson, C., Chen, R., Blount, A., Berggren, T., BilezikjIan, L., Sawchenko, P., Vale, W., 1995. Identification of a second corticotropin releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. USA 92, 2969-2973.
18. Rivier, J., Rivier, C., Vale, W., 1984. Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. effect on ACTH secretion in the rat. Science 224, 889-891.
19. 2+)-regulated transcription factor phosphorylated by calmodulin-dependent kineses. Science (Washington DC) 252, 1427-1430.
20. Spina, M., Merlo-Pich, E., Chan, R.K.W., Basso, A.M., Rivier, J., Vale, W., Koob, G.F., 1996. Appetite-suppression effects of urocortin a CRF-releated neuropeptide. Science (Washington DC) 273, 1561-1564.
21. 2 receptor for corticotropin-releasing factor. Biochem. Biophysica. Acta. 1352, 129-132.
22. Weiland, G.A., Molinoff, P.B., 1981. Quantitative analysis of drug-receptor interactions: determination of kinetics and equilibrium properties. Life Sci. 29, 313-330.